Lisi Peng
-
- Pancreatic and Hepatic Oncology Research 12
- Colorectal Cancer Screening and Detection 2
-
- Pancreatitis Pathology and Treatment 9
- Pediatric Hepatobiliary Diseases and Treatments 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Neuroendocrine Tumor Research Advances 2
-
- Epigenetics and DNA Methylation 2
- Cited by
- PollutionOncologyDermatology
- Journals
- Nature Communications (1 paper)Gastroenterology (1 paper)Journal of Hazardous Materials (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Lisi Peng
24 papers receiving 248 citations
Peers
Comparison fields: 5 of 68
- Pollution 42
- Oncology 100
- Dermatology 23
- Industrial and Manufacturing Engineering 22
- Cancer Research 32
Countries citing papers authored by Lisi Peng
This map shows the geographic impact of Lisi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisi Peng more than expected).
Fields of papers citing papers by Lisi Peng
This network shows the impact of papers produced by Lisi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisi Peng. The network helps show where Lisi Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lisi Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 44 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 23 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 20 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 8 | |
| 17 | 2020 | 4 | |
| 18 | 2019 | 29 | |
| 19 | 2019 | 2 | |
| 20 | HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. | 2018 | 1 |
About Lisi Peng
Lisi Peng is a scholar working on Oncology, Complementary and Manual Therapy and Surgery, having authored 24 papers that have together received 251 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (9 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Epigenetics and DNA Methylation (2 papers), Colorectal Cancer Screening and Detection (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Pollution (42 citations), Oncology (100 citations) and Dermatology (23 citations). Lisi Peng has collaborated with scholars based in China, United States and India. Frequent co-authors include Haojie Huang, Haojie Huang, Liqi Sun, Keliang Li, Zhendong Jin, Zhendong Jin, Deyu Zhang, Fang Cui, Zhao‐Shen Li and Wanshun Li. Their work appears in journals such as Nature Communications, Gastroenterology and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.